期刊文献+

离子注入介导甘草基因组DNA转化酵母菌 被引量:4

Transformation of Glycyrrhiza uralensis genomic DNA into yeast mediated by ion implantation
原文传递
导出
摘要 目的以甘草酸为目标产物,探讨氮离子(N+)和氩离子(Ar+)注入介导甘草基因组DNA在酵母菌中的转化。方法通过N+和Ar+注入介导乌拉尔甘草基因组DNA在异常汉逊酵母Hansenula anomala中随机转化,转化后的酵母菌经斜面传代和液体培养后,用醋酐-浓硫酸定性检识和RP-HPLC方法,检测重组酵母菌培养液中甘草酸和甘草次酸的量。结果获得了生物合成甘草酸和/或甘草次酸的重组酵母菌5株。液体培养96h,RP-HPLC测试其培养液中甘草酸最高量114.49mg/L,18α-甘草次酸和18β-甘草次酸最高量分别为0.56和0.81mg/L。TLC检测发现其中1株重组酵母菌的培养液中含一种未知的红色组分。结论采用离子注入介导甘草基因级DNA大分子转化技术,可获得易于人工培养的产生甘草酸等次生代谢产物的微生物工程菌株。 Objective With the sole object of glycyrrhizic acid products, the methods were investigated for Glycyrrhiza uralensis genomic DNA transformation into Hansenula anomala by nitrogen and argon ion implantation. Methods The genomic DNA from G. uralensis was randomly transferred into H. anomala by nitrogen and argon ion bombardment. The recombined yeasts were cultured by the slant and liquid cultivation, in which the contents of glycyrrhizic acid and glycyrrhetic acid were determined by acetic anhydried-H2SO4 qualitative test and RP HPLC determination. Results Five recombined yeast strains that produced glycyrrhizic acid and glycyrrhetic acid were obtained. After cultured in liquid medium for 96 h, the highest content of glycyrrhizic acid in the cultivation liquid was 114.49 mg/L and that of 18α-glycyrrhetic acid and 18β-glycyrrhetic acid were respectively 0.56 and 0.81 mg/L by RP-HPLC. A kind of unknown red component was found in the cultivation liquid of one reeombined strain by TLC. Conclusion The reeombined yeast strains of producing glycyrrhizic acid could be obtained G. uralensis genomic DNA transformation into yeast mediated by the ion implantation.
出处 《中草药》 CAS CSCD 北大核心 2010年第3期461-464,共4页 Chinese Traditional and Herbal Drugs
基金 国家自然科学基金项目(30560182 30960006)
关键词 离子注入 甘草基因组DNA 重组酵母菌 甘草酸 ion implantaton Glycyrrhiza uralensis F. genome DNA recomhined yeast glycyrrhizic acid
  • 相关文献

参考文献11

二级参考文献28

共引文献22

同被引文献47

  • 1尧俊英,李景原,李清禄.低能离子束介导转基因技术[J].生物学通报,2006,41(1):24-25. 被引量:5
  • 2田庆来,官月平,张波,刘会洲.甘草有效成分的药理作用研究进展[J].天然产物研究与开发,2006,18(2):343-347. 被引量:180
  • 3王辂,褚以文.微生物来源先导化合物的研究策略[J].中国天然药物,2006,4(3):162-167. 被引量:9
  • 4曹福祥.次生代谢[M].长沙:国防科技大学出版社,2003.
  • 5KNIGHT V,SANGLIER J J,DITULLIO D,et al.Diversifying microbial nat-ural products for drug discovery[J].Appl Microbiol Biotechnol,2003,62:4462-4581.
  • 6RO D K,PARADISE E M,OUELLET M,et al.Production of the antimalar-ial drug precursor artemisinic acid in engineered yeast[J].Nature,2006,440:940-943.
  • 7FENG H Y,YU Z L,CHU P K.Ion implantation of organisms[J].Mat Sci Eng R,2006,54:49-120.
  • 8LU J,JIN X,MAO P H,et al.Transfer of Ephedra genomic DNA to yeasts by ion implantation[J].Appl Biochem Biotechnol,2009,158(3):571-581.
  • 9SRINIVAS G,ANTO R J.Emodin induces apoptosis of human cervical cancer cells though poly(APD-ribose)polymerase cleavage and activa-tion of caspase-9[J].Eur J Pharmacol,2003,473(2/3):117-125.
  • 10HARA H,HIRAMATSU H,ADACHI T.Pyrroloquinoline Quinone is a Potent Neuroprotective Nutrient Against6-Hydroxydopamine-Induced Neurotoxicity[J].Neurochem Res,2007,32:489-495.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部